3 stories mentioning KRROUpdated 34d ago
Every FINWIRES story that references KRRO, newest first.
Jean Francois Formela, Director, on July 02, 2026, sold 110,023 shares in Korro Bio (KRRO) for $1,542,970. Following the Form 4 filing with the SEC, Formela has control over a total of 852,861 common shares of the company, with 852,861 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1703647/000103057526000006/xslF345X05/form4-07072026_100726.xml
Jean Francois Formela, Director, on June 22, 2026, sold 171,405 shares in Korro Bio (KRRO) for $2,458,582. Following the Form 4 filing with the SEC, Formela has control over a total of 169,556 common shares of the company, with 169,556 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1703647/000103057526000004/xslF345X05/form4-06252026_120611.xml
Korro Bio (KRRO) has an average rating of buy and mean price target of $20.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
